Chapters
Skip to …
Status | Drug name | NICE TAs | Comments |
---|---|---|---|
![]() |
Alfuzosin M/R tablets | ||
![]() |
Alfuzosin tablets | ||
![]() |
Alprostadil cream (Vitaros) |
Specialist initiation. For patients who would otherwise use alprostradil injection. |
|
![]() |
Alprostadil injection | ||
![]() |
Aviptadil 25mcg / Phentolamine 2mg intracavernosal injection (Invicorp®) |
Approved on formulary December 2017. Specialist initiation. Third line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil. To be reviewed within 12 months to assess alprostadil supply issues and patent expiry |
|
![]() |
BCG (OncoTice®) bladder installation | ||
![]() |
Bethanechol chloride | ||
![]() |
Bladder cocktail urological solution | ||
![]() |
Botulinum toxin type A | ||
![]() |
Catheter patency solution - sodium chloride | ||
![]() |
Chlorhexidine bladder wash | ||
![]() |
Chondroitin sulfate urological solution (Uracyst®) | ||
![]() |
Dimethyl sulphoxide bladder installation 50% | ||
![]() |
Doxazosin | ||
![]() |
Duloxetine capsule | ||
![]() |
Glycine | ||
![]() |
Hyuralonic acid (Hyacyst®) | ||
![]() |
Mirabegron | ||
![]() |
Oxybutynin M/R tablets | ||
![]() |
Oxybutynin patch (Kentera) |
If first line is not tolerated, following specialist advice |
|
![]() |
Oxybutynin tablets | ||
![]() |
Potassium citrate mixture BP | ||
![]() |
Sildenafil tablets#7.4 |
Sildenafil tablets generic |
|
![]() |
Sodium bicarbonate powder | ||
![]() |
Sodium citrate | ||
![]() |
Solifenacin tablets | ||
![]() |
Tadalafil 10mg |
High relative cost. In line with SLS criteria. Four tab per month - on demand. Non-formulary for LUTS in BPS. |
|
![]() |
Tolterodine M/R capsules |
High relative cost. Second line. |
|
![]() |
Tolterodine tablets | ||
![]() |
Trospium MR capsules |
Over 65 year old |
|
![]() |
Trospium tablets |
Over 65 year old |
|
![]() |
Vacuum pumps |
Green - if in line with SLS criteria |
|
![]() |
Vacuum pumps#red |
Red - if not in line with the SLS criteria |